IDiyas

For the Inventor, By the Inventor

Ledyard, CT, United States of America

Nicholas A Saccomano

USPTO Granted Patents = 16

Average Co-Inventor Count = 2.0

ph-index = 8

Forward Citations = 140(Granted Patents)


Location History:

  • Groton, CT (US) (1993)
  • Ledyard, CT (US) (1989 - 1998)

Company Filing History:

goldMedal16 out of 4,455 
 
Pfizer Corporation
 patents

Years Active: 1989-1998

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5804554 - Calcium channel blocking polypeptides from filistata hibernalis (1998-09-08),
2. 5756462 - Pore forming peptides from Geolycosa riogrande (1998-05-26),
3. 5627154 - Calcium channel blocking polypeptides from Heteropoda venatoria (1997-05-06),
4. 5599559 - Calcium channel blocking polypeptide from agelenopsis aperta and (1997-02-04),
5. 5459145 - Calcium independent camp phosphodiesterase inhibitor antidepressant (1995-10-17),
6. 5414127 - Calcium independent camp phosphodiesterase inhibitor antidepressant (1995-05-09),
7. 5395935 - Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents (1995-03-07),
8. 5294730 - Calcium independent camp phosphodiesterase inhibitor antidepressant (1994-03-15),
9. 5270206 - Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived (1993-12-14),
10. 5227397 - Polyamines and polypeptides useful as antagonists of excitatory amino (1993-07-13),
11. 5196426 - Calcium independent C amp phosphodiesterase inhibitor antidepressant (1993-03-23),
12. 5185369 - Synthetic heteroaryl polyamines as excitatory amino acid (1993-02-09),
13. 5128358 - Aryl substituted nitrogen heterocyclic antidepressants (1992-07-07),
14. 5122596 - Polypeptides useful as blockers of calcium channels (1992-06-16),
15. 5037846 - Indolyl-3 polyamines and their use as antagonists of excitatory amino (1991-08-06),

Title: Celebrating the Innovative Work of Nicholas A. Saccomano

Introduction: Nicholas A. Saccomano, based in Ledyard, Connecticut, has made significant contributions to the field of biotechnology through his innovative inventions. With 16 patents to his name, he demonstrates a commitment to pushing the boundaries of scientific discovery.

Latest Patents: Among his most recent patents are groundbreaking inventions, including "Calcium Channel Blocking Polypeptides from Filistata Hibernalis" and "Pore Forming Peptides from Geolycosa Riogrande." These innovations reflect his expertise in molecular biology and pharmacology, offering potential advancements in therapeutic applications.

Career Highlights: Nicholas A. Saccomano has established a prominent career at Pfizer Corporation, a leading global biopharmaceutical company. His work at Pfizer highlights his role in developing novel therapeutic agents aimed at addressing various medical conditions. His dedication to innovation continues to impact the biotechnology landscape.

Collaborations: Throughout his career, Saccomano has collaborated with esteemed colleagues, including Robert A. Volkmann and Fredric J. Vinick. These partnerships have facilitated the exchange of ideas and resources, leading to the successful development of numerous patents and research initiatives.

Conclusion: Nicholas A. Saccomano stands out as a prominent inventor whose contributions in the biotech sector have the potential to enhance healthcare solutions. His ongoing work at Pfizer Corporation and collaborations with fellow innovators suggest that he will continue to influence the field of biotechnology for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…